These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21375572)

  • 1. Nurse-delivered and doctor-delivered care in an attention deficit hyperactivity disorder follow-up clinic: a comparative study using propensity score matching.
    Foreman DM; Morton S
    J Adv Nurs; 2011 Jun; 67(6):1341-8. PubMed ID: 21375572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
    Power TJ; Mautone JA; Manz PH; Frye L; Blum NJ
    Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention deficit/hyperactivity disorder: working the system for better diagnosis and treatment.
    Stevens S
    J Pediatr Nurs; 2005 Feb; 20(1):47-51. PubMed ID: 15834359
    [No Abstract]   [Full Text] [Related]  

  • 4. Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.
    Janols LO; Liliemark J; Klintberg K; von Knorring AL
    Nord J Psychiatry; 2009 Nov; 63(6):508-16. PubMed ID: 19958258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands.
    Sasané R; Hodgkins P; Meijer W
    Curr Med Res Opin; 2010 Nov; 26(11):2565-74. PubMed ID: 20863165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence and belief in attention deficit hyperactivity disorder. Reintroduction of methylphenidate in Italy needs careful monitoring.
    Bonati M; Impicciatore P; Pandolfini C
    BMJ; 2001 Mar; 322(7285):556. PubMed ID: 11263458
    [No Abstract]   [Full Text] [Related]  

  • 7. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult attention-deficit/hyperactivity disorder: a survey of diagnosis and treatment practices.
    Knutson KC; O'Malley M
    J Am Acad Nurse Pract; 2010 Nov; 22(11):593-601. PubMed ID: 21054633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in medications administered in schools.
    McCarthy AM; Kelly MW; Johnson S; Roman J; Zimmerman MB
    J Sch Nurs; 2006 Apr; 22(2):102-7. PubMed ID: 16563033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nurse prescribing roles in acute care: an evaluative case study.
    Jones K; Edwards M; While A
    J Adv Nurs; 2011 Jan; 67(1):117-26. PubMed ID: 21073502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of methylphenidate prescription among school-aged children in a Swiss population: increase in the number of prescriptions in the Swiss Canton of Vaud, from 2002 to 2005, and changes in patient demographics.
    Gumy C; Huissoud T; Dubois-Arber F
    J Atten Disord; 2010 Nov; 14(3):267-72. PubMed ID: 20484708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Massive variation in Ritalin prescribing.
    Gainsbury S
    Health Serv J; 2008 Jul; ():5. PubMed ID: 18705035
    [No Abstract]   [Full Text] [Related]  

  • 13. Attention-deficit/hyperactivity disorder in children and adolescents: closing diagnostic, communication, and treatment gaps.
    Vierhile A; Robb A; Ryan-Krause P
    J Pediatr Health Care; 2009; 23(1 Suppl):S5-23. PubMed ID: 19084757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention deficit/hyperactivity disorder: a review and update.
    Cormier E
    J Pediatr Nurs; 2008 Oct; 23(5):345-57. PubMed ID: 18804015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
    Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
    Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A university physician's duty to nonpatient students.
    Geppert C
    Virtual Mentor; 2012 May; 14(5):378-82. PubMed ID: 23351202
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlating family nurse practitioners' perspectives of adult ADD/ADHD with employed pharmacotherapy: a pilot study.
    Martinson J; Tang HY
    J Am Acad Nurse Pract; 2010 Aug; 22(8):424-30. PubMed ID: 20670268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myth: Seeing a nurse practitioner instead of a doctor is second-class care.
    Canadian Health Services Research Foundation
    J Health Serv Res Policy; 2011 Apr; 16(2):124-5. PubMed ID: 21447846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.